PharmEasy Parent API Holdings Debt Funding News: ₹1,700 Crore Raise to Repay Debt
PharmEasy raises ₹1,700 Cr via NCDs to repay Goldman Sachs loan. Losses are down, Thyrocare profits up, IPO talks back. Bold strategy or risky gamble?
PharmEasy raises ₹1,700 Cr via NCDs to repay Goldman Sachs loan. Losses are down, Thyrocare profits up, IPO talks back. Bold strategy or risky gamble?